Ascentage Pharma Group International American Depository Shares
IPOA Leader in the Discovery and Development of First- and Best-in-class Small Molecule Cancer Therapies -
Public · Suzhou, China · Founded 2009
- Headquarters
- Suzhou
- Employees
- 201–500
- Founded
- 2009
- Business Model
- B2B
- Website
- ascentage.com
- Last Round
- Corporate RoundJun 2024
- Rounds
- 3
- Type
- Public
About
Global integrated biopharmaceutical company discovering, developing, and commercializing first- and best-in-class therapies for unmet medical needs.
Summary
Ascentage Pharma Group International American Depository Shares is a Biotech company based in Suzhou, China, founded in 2009. Its most recent funding was a Corporate Round in Jun 2024. Investors include Takeda (JP), Future Industry Investment Fund and Oriza Seed Fund.
Tech & App Stack
Funding History
Jan 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ascentage-pharma-group-international-american-depository-shares"><img src="https://indexed.vc/api/badge/company/ascentage-pharma-group-international-american-depository-shares" alt="Ascentage Pharma Group International American Depository Shares on Indexed.vc" width="260" height="76" /></a>